Therapeutic Discovery Project Defending America's Competitiveness in Biotechnology

Type:

Video

Capital formation challenges in the industry have forced many biotech companies to halt projects, lay off staff or shutdown all together. Our analysis shows that the industry is approximately one-quarter smaller than it was in 2008.

May 25, 2011 Bob Klein, 2010 Biotechnology Humanitarian Award Winner	May 25, 2011 International BioGENEius Challenge: The importance of this competition	May 21, 2011 Worldview: A Global Biotechnology Perspective	May 19, 2011 Prof. Alan Trounson, Ph.D., President of the California Institute for Regenerative Medicine
May 11, 2011 Bernard Siegel speaks about recent developments in stem cell research	May 9, 2011 Lovell Jones, PhD – 2011 Humanitarian Award judge	May 9, 2011 Bonnie Fendrock, Cofounder, President and CEO of Hepregen Corporation	May 9, 2011 Peter Soelkner, Managing Director of Vetter Pharma International